
Decoding the Enigma of Exercise Intolerance: Genetic Testing and Beyond
Discover the role of genetic testing in diagnosing exercise intolerance, identifying genetic mutations, and developing personalized treatment plans for various diseases.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Discover the role of genetic testing in diagnosing exercise intolerance, identifying genetic mutations, and developing personalized treatment plans for various diseases.

Pediatric cardiomyopathy genes, gastric cancer surveillance, a prostate cancer risk algorithm using SNPs and fructose studies in type 2 diabetes are summarised.

Once called complex partial seizures, these episodes bring brief loss of awareness; hippocampal MRI, EEG, smartwatch detection and genetic testing are all discussed.

Seizures affecting both sides of the brain appear as tonic-clonic, absence or myoclonic events, with causes from GABAA receptor mutations to tuberous sclerosis.

EGFR amplification, EGFRvIII and ADD3 loss are described as prognostic markers in GBM, alongside LSD1 and angiogenesis targets and CRISPR-Cas9 research.

Discover the benefits of genetic testing in diagnosing and managing hand muscle atrophy caused by conditions like Charcot-Marie-Tooth disease and smoking-induced muscle impairment.

One side of the body overgrows in hemihypertrophy, sometimes with Beckwith-Wiedemann syndrome. Studies advise abdominal tumor checks and orthopedic support.

Explore the latest findings on genetic causes of hemiplegia/hemiparesis and the crucial role of genetic testing in diagnosis, treatment, and family risk assessment.